Botanical species · safety record

Hedeoma pulegioides

The EFSA Compendium of Botanicals holds 4 constituent measurements and 2 adverse-effect records for Hedeoma pulegioides. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Hedeoma pulegioides (L.) Pers.

4Constituent measurements

2Safety records

4Cited sources

6Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 6 licensed products naming Hedeoma pulegioides as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

Whole plant(s)

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
(+)-pulegone	Live plants	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
Menthone	Unspecified	—	1.4 Percent	Gaschromatography (GC)	Resolve DOI
P-mentha-1,4(8)-dien-3-one	Unspecified	—	1.4 Percent	Gaschromatography (GC)	Resolve DOI
Trans-isopulegone	—	—	—	—	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Nephrotoxicity	Urogenital: kidneys	Unspecified	—	—	Case report	Resolve DOI
Systemic	Liver	Unspecified	—	—	Case report	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

HANDA, KL., NIGAM, IC., SMITH, DM., LEVI, L. ESSENTIAL OILS + THEIR CONSTITUENTS .23. CHEMOTAXONOMY OF GENUS MENTHA. Journal of pharmaceutical sciences, 1964, vol. 53, no. 11, p. 1407-&. DOI
Wishart, DS., Jewison, T., Guo, AC., Wilson, M., Knox, C., Liu, Y., Djoumbou, Y., Mandal, R., Aziat, F., Dong, E., Bouatra, S., Sinelnikov, I., Arndt, D., Xia, J., Liu, P., Yallou, F., Bjorndahl, T., Perez-Pineiro, R., Eisner, R., Allen, F., Neveu, V., Greiner, R., Scalbert, A. (-)-trans-Isopulegone (HMDB35741).. Human metabolome database, 2012, vol. 3.0.
Luyckx, V.A. Nephrotoxicity of Alternative Medicine Practice. Advances in chronic kidney disease, 2012, vol. 19, no. 3, p. 129-141. DOI
SLECKMAN, BP., SHERMA, J., MINEO, LC. DETERMINATION OF PULEGONE IN H-PULEGIOIDES AND PEPPERMINT OIL BY THIN-LAYER CHROMATOGRAPHY WITH DENSITOMETRY . Journal of liquid chromatography, 1983, vol. 6, no. 7, p. 1175-1182. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature